Siegfried Holding AG to Acquire Noramco, Extractas Biosciences and Purisys from SK Capital Partners

Noramco Acquires Cambrex Drug Product Business Unit (Halo Pharmaceuticals)

November 2, 2023

Pharmaceuticals

Noramco has completed the acquisition of the Cambrex Drug Product Business Unit (previously Halo Pharmaceuticals), adding drug product formulation development, clinical and commercial manufacturing, and packaging capabilities from sites in Mirabel, Québec and Whippany, New Jersey. The purchase expands Noramco's service offering beyond APIs, brings nearly 400 employees into the Noramco group, and represents Cambrex's strategic divestiture to focus on its drug substance and analytical testing businesses.

Ampersand Capital Partners Acquires Purna Pharmaceuticals

February 12, 2026

Pharmaceuticals

Ampersand Capital Partners acquired Purna Pharmaceuticals, a Belgian contract development and manufacturing provider of liquid and semi-solid pharmaceutical dosage forms. The investment positions Purna to collaborate with Ampersand portfolio company MedPharm to create a trans‑Atlantic topical and transdermal development and manufacturing offering; Creafund, Purna's prior investor, supported the company for more than a decade and was referenced in the transaction announcement.

Nalka Acquires Norres Baggerman Group from Triton

May 26, 2023

Manufacturing

Nalka DACH Investments SA SICAF-RAIF (Nalka) has acquired Norres Baggerman Group (NORRES), a European manufacturer of industrial plastic hoses, from the Triton Smaller Mid-Cap Fund I (advised by Triton). NORRES, headquartered in Gelsenkirchen, Germany, employs around 400 people across six production facilities and 15 sales/warehousing sites and serves end markets including agriculture, food & pharma, and plastics processing.

AmerisourceBergen Acquires PharmaLex for €1.28 Billion

December 31, 2022

Healthcare Services

AmerisourceBergen Corporation signed a definitive agreement to acquire PharmaLex Holding GmbH for €1.28 billion in cash. The deal is intended to expand AmerisourceBergen’s global biopharma services platform by adding PharmaLex’s tech-enabled, regulatory-focused life sciences expertise.

SK Capital to Invest in Swixx BioPharma in Deal Valued at Over €1.5 Billion

December 15, 2025

Healthcare Services

SK Capital Partners, through an affiliate, reached a definitive agreement to invest in Swixx BioPharma AG as the company looks to accelerate its next phase of growth and global expansion. The transaction values Swixx at more than €1.5 billion, with Swixx co-founders and CEO/CFO retaining significant ownership and existing investors HBM Healthcare Investments and Mérieux Equity Partners remaining shareholders.

Chugai Pharmaceutical to Acquire Renalys Pharma

October 24, 2025

Biotechnology

Chugai Pharmaceutical Co., Ltd. will acquire Renalys Pharma, Inc. through a definitive stock purchase agreement. The transaction includes an upfront payment of JPY 15.0 billion and potential earn-outs of up to JPY 16.0 billion tied to regulatory and sales milestones for sparsentan in Japan, South Korea, and Taiwan.